Sklamberg Quoted in Bloomberg Law on Califf Senate Hearing

Life Sciences & Healthcare Regulatory partner Howard Sklamberg was quoted in a recent article from Bloomberg Law, “Biden’s FDA Pick Gets Bipartisan Support at Senate Panel Hearing.” The article discusses the Senate panel hearing for Robert Califf, President Biden’s pick to lead the Food and Drug Administration. Sklamberg, who held a variety of roles at the FDA from 2010 to 2017, comments on Califf's previous tenure as FDA commissioner and his relationship with Capitol Hill.

» Read the full article (subscription required).